Letter from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes

The letter sets out the scientific and public health rationale for the dosing schedule for the AstraZeneca vaccine and the change to the dosing schedule for the second dose of the Pfizer vaccine.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in